Reset filter
Palavras-chave
dermatologie ×
Mostrar mais Palavras-chave
Índice
  1. 1. Estudo clínico
    1. 1.1. Inclusão/exclusão
    1. 1.2. Anamnese
    1. 1.3. Exame físico
    1. 1.4. Score
    1. 1.5. Diagnóstico com aparelhos
    1. 1.6. Laboratório
    1. 1.7. Patologia/histologia
    1. 1.8. Esclarecimento/consentimento
    1. 1.9. Terapia
    1. 1.10. Relatório da operação
    1. 1.11. Evento indesejado
    1. 1.12. Seguimento
  2. 2. Documentação de rotina
  3. 3. Estudos de registo/coortes
  4. 4. Garantia da qualidade
  5. 5. Padrão de dados
  6. 6. Questionário do paciente
  7. 7. Especialidade médica
Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

108 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - IMD Report - Rheumatic Diseases; Systemic Lupus Erythematosus or Cutaneous Lupus; Sjogren's Syndrome (Report Final and Annex Report 2 Final)

- 02/11/2020 - 1 Formulário, 25 Grupos de itens, 95 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Rheumatic Diseases, Rheumatic Diseases - Signs and Symptoms, Rheumatic diseases - Other signs and symptoms, Rheumatic diseases - Other signs and symptoms , Rheumatic diseases - Diagnostic Test Results, Rheumatic diseases - Other Diagnostic Test Results , Rheumatic diseases - Other Diagnostic Test Results , Rheumatic diseases - Other diagnostic Procedure, Systemic Lupus Erythematosus or Cutaneous Lupus, Systemic Lupus Erythematosus or Cutaneous Lupus - Signs and symptoms (supporting the final diagnosis), Systemic Lupus Erythematosus or Cutaneous Lupus - Other Signs and symptoms, Systemic Lupus Erythematosus or Cutaneous Lupus - Other Signs and symptoms , Systemic Lupus Erythematosus or Cutaneous Lupus - Diagnostic Test Results, Systemic Lupus Erythematosus or Cutaneous Lupus - Other Diagnostic Test Results , Systemic Lupus Erythematosus or Cutaneous Lupus - Other Diagnostic Test Results , Systemic Lupus Erythematosus or Cutaneous Lupus - Other diagnostic Procedure , Sjogren's Syndrome, Sjogren's Syndrome - Signs and symptoms (supporting the final diagnosis), Sjogren's Syndrome - Other Signs and symptoms , Sjogren's Syndrome - Other Signs and symptoms , Sjogren's Syndrome - Diagnostic Test Results , Sjogren's Syndrome - Other Diagnostic Test Results , Sjogren's Syndrome - Other Diagnostic Test Results , Sjogren's Syndrome - Other diagnostic Procedure
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Screening Visit 1 Psoriasis NCT02695940

- 27/09/2021 - 1 Formulário, 10 Grupos de itens, 62 Elementos de dados, 1 Idioma
Grupos de itens: Administrative data, Eligibility criteria, Demography, Medical History, Treated body regions, Vital signs, ECG, Blood sample, Urine sample, miscellaneous
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - Screening - Primary Tumor Characteristics; Regional Lymph Node Status; Tumor Sample (Annex Report 2 Final Annex Report 2 Final)

- 20/09/2021 - 1 Formulário, 4 Grupos de itens, 27 Elementos de dados, 1 Idioma
Grupos de itens: Administrative, Primary Tumor Characteristics, Regional Lymph Node Status, Tumor Sample
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Eligibility NCT00980629 Atopic Dermatitis - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 19 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00980629

Eligibility NCT00757523 Acne Vulgaris - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 24 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00757523

Eligibility NCT00777127 Actinic Keratosis - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 26 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00777127

Eligibility NCT00408187 Psoriasis - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 30 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00408187

Eligibility NCT00669708 Compensate the Roughness of the Skin - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 9 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00669708

Eligibility NCT00445081 Atopic Dermatitis - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 32 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00445081

Eligibility NCT00606450 Psoriasis - Eligibility

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 24 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00606450

Eligibility NCT00245765 Chronic Plaque Psoriasis - Eligibility

- 17/09/2021 - 1 Formulário, 2 Grupos de itens, 12 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00245765

Eligibility NCT00574249 Chronic Plaque Psoriasis - Eligibility

- 17/09/2021 - 1 Formulário, 2 Grupos de itens, 11 Elementos de dados, 2 Idiomas
Grupos de itens: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00574249

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial